Preexisting Virus-Specific T Lymphocytes-Mediated Enhancement of Adenovirus Infections to Human Blood CD14+ Cells

scientific article published on 13 February 2019

Preexisting Virus-Specific T Lymphocytes-Mediated Enhancement of Adenovirus Infections to Human Blood CD14+ Cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/V11020154
P932PMC publication ID6409799
P698PubMed publication ID30781810

P50authorCaijun SunQ90950300
P2093author name stringLing Chen
Jin Zhao
Pingchao Li
Ruiting Li
Fengling Feng
P2860cites workHIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygonsQ27330424
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapyQ33633277
Scavenger receptor-mediated Ad5 entry and acLDL accumulation in monocytes/macrophages synergistically trigger innate responses against viral infection.Q52572435
Host Immune Response to Influenza A Virus Infection.Q52647758
Effects of hypergravity on adipose-derived stem cell morphology, mechanical property and proliferation.Q53437339
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.Q54217627
Humoral immune responses to infection: common mechanisms and unique strategies to combat pathogen immune evasion tactics.Q54267111
An adenovirus serotype 2-vectored ebolavirus vaccine generates robust antibody and cell-mediated immune responses in mice and rhesus macaques.Q55010162
HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic VirusesQ56378150
Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometryQ58414495
Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus MonkeysQ58572686
Delivery of immunotherapy with peptide-pulsed blood in macaquesQ62129131
Two-Faced Immunity? The Evidence for Antibody Enhancement of Malaria TransmissionQ62738101
Centrifugation facilitates transduction of green fluorescent protein in human monocytes and macrophages by adenovirus at low multiplicity of infectionQ64377433
Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cellsQ64380031
Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsetsQ70428566
Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanomaQ84834335
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexesQ34671059
The effect of centrifugation condition on mature adipocytes and adipose stem cell viabilityQ34699321
Cytotoxic T lymphocytes: all roads lead to deathQ34716318
Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation stateQ34763398
Circumventing antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaquesQ36276187
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't knowQ36394962
A serological survey of human adenovirus serotype 2 and 5 circulating pediatric populations in Changchun, China, 2011Q36448142
Biologic Effects of InterferonsQ36612328
A pathogenic picornavirus acquires an envelope by hijacking cellular membranesQ36781367
Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeysQ36827361
Intracellular antibody-bound pathogens stimulate immune signaling via the Fc receptor TRIM21.Q36903830
Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United StatesQ37015368
Adenoviruses in immunocompromised hostsQ37293675
From the first to the third generation adenoviral vector: what parameters are governing the production yield?Q37326995
Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan AfricaQ38480709
Talimogene laherparepvec (T-VEC) for the treatment of advanced melanomaQ38534285
Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?Q38598484
Fc receptors in antibody-dependent enhancement of viral infectionsQ38615396
Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern ChinaQ39766587
Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene deliveryQ39869620
Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeysQ39892112
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trialQ40075275
An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in MiceQ40076766
Dermal CD14(+) Dendritic Cell and Macrophage Infection by Dengue Virus Is Stimulated by Interleukin-4.Q40177309
Adenovirus type 5 interactions with human blood cells may compromise systemic delivery.Q40297306
Endogenous production and peripheral blood levels of granulocyte-macrophage (GM-) and granulocyte (G-) colony-stimulating factorsQ40391301
Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent simian immunodeficiency virus-specific T cell immunity in monkeysQ40609240
Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene.Q40804492
Vaccine Engineering with Dual-Functional Mineral Shell: A Promising Strategy to Overcome Preexisting ImmunityQ41097174
Inhibitory effect of interferon-gamma on adenovirus replication and late transcriptionQ43413429
Recombinant human interferon-gamma inhibits adenovirus multiplication in vitroQ43609414
From bench to almost bedside: the long road to a licensed Ebola virus vaccineQ44106264
Development of an adenovirus vector vaccine platform for targeting dendritic cellsQ47248134
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectAdenoviridaeQ193447
T LymphocytesQ57358733
P304page(s)154
P577publication date2019-02-13
P1433published inVirusesQ7935305
P1476titlePreexisting Virus-Specific T Lymphocytes-Mediated Enhancement of Adenovirus Infections to Human Blood CD14+ Cells
P478volume11

Search more.